Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Molecular Diagnostics: Current and Emerging Technologies
     3.1 Nucleic Acid Amplification based Technologies
            3.1.1 Polymerase Chain Reaction (PCR)
            3.1.2 Real Time PCR
            3.1.3 Multiplex PCR
            3.1.4 Transcription Mediated Amplification (TMA)
            3.1.5 Nucleic Acid Sequence based Amplification (NASBA)
            3.1.6 Strand Displacement Amplification (SDA)
     3.2 Hybridization based Technologies
            3.2.1 Microarray
            3.2.2 Fluorescence in Situ Hybridization (FISH)
     3.3 Sequencing based Technologies

4. Industry Trends and Drivers
     4.1 Expansions and Strategic Activity Fuelling Growth amongst Leading Players
     4.2 HAI’s Diagnostics to Diversify Greatly
     4.3 Next-Generation Technologies Growing in the Market

5. Industry Overview: Current & Future Market Analysis to 2015
     5.1 Molecular Diagnostics Market
     5.2 Infectious Disease Molecular Diagnostics Market

6. Infectious Disease Molecular Diagnostics: Market Segments
     6.1 HIV
            6.1.1 Global Disease Burden
            6.1.2 Market Size: Current and Future Analysis to 2015
            6.1.3 FDA Approved Tests
            6.1.4 Market Activities
     6.2 Hepatitis
            6.2.1 Global Disease Burden (Hepatitis B and C)
            6.2.2 Market Size: Current and Future Analysis to 2015
            6.2.3 FDA Approved Tests
            6.2.4 Market Activities
     6.3 Human Papillomavirus (HPV)
            6.3.1 Global Disease Burden
            6.3.2 Market Size: Current and Future Analysis to 2015
            6.3.3 FDA Approved Tests
            6.3.4 Market Activities
     6.4 Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (GC)
            6.4.1 Global Disease Burden
            6.4.2 Market Size: Current and Future Analysis to 2015
            6.4.3 FDA Approved Tests
            6.4.4 Market Activities

7. Regulatory Framework

8. Competitive Landscape
     8.1 Abbott Laboratories
     8.2 Becton, Dickinson and Company
     8.3 Siemens
     8.4 bioMérieux
     8.5 Gen-Probe
     8.6 Cepheid
     8.7 Qiagen NV
     8.8 Roche